Recent studies have found alongside older age and chronic health conditions, obesity is a risk factor for becoming seriously ill with COVID-19.
It’s true a number of the health conditions which we know increase the risk of severe illness from COVID-19 are also associated with obesity. These include type 2 diabetes, high blood pressure, heart disease and respiratory disease.
But new research suggests obesity independently is a strong predictor of severe illness, particularly in those aged under 60 years.
While it’s an imperfect measure for an individual person, BMI is very useful in comparing health and weight across a population and between groups.
For adults, overweight is a BMI of 25 or above, but less than 30kg/m². For a woman of average height (162 cm), this would be equivalent to a weight of 66kg or above, and for a man of average height (176 cm), a weight of 78kg or above.
Obesity is defined as a BMI of 30kg/m² or above. This equates to a weight of 79kg and above for a woman and 93kg and above for a man, both of average height.
One study from China looking at data from 112 patients reported overweight and obesity were almost five times more prevalent in patients with COVID-19 who died (88%) compared to those who survived (19%).
Preliminary data from another Chinese study involving 383 patients, although not yet peer reviewed, suggests overweight or obesity more than doubled the risk of developing severe pneumonia as a result of COVID-19, particularly in men.
Researchers in France found almost half of 124 patients admitted to an intensive care unit (ICU) with COVID-19 had a BMI in the obese range. This was nearly double the rate of a comparison group of ICU patients with severe acute respiratory disease unrelated to COVID-19.
Further, the need for mechanical ventilation increased with increasing BMI.
A UK surveillance study of patients admitted to intensive care with COVID-19 reported almost three-quarters (75%) of the 6,720 patients had a BMI in the overweight or obese range, which is greater than the population prevalence of overweight and obesity in adults in the UK (around 67%).
Although some of these studies factored in chronic conditions when reporting their results, it’s difficult to separate all of the conditions associated with obesity that may contribute to some degree to the poorer outcomes.
So it’s likely that some – but not all – of the increased risk of severe COVID-19 associated with obesity could be due to people having other chronic conditions.
It seems obesity may have more of an impact on the severity of COVID-19 in young people, according to two studies from New York.
One study of 3,615 people who tested positive for COVID-19 found those aged under 60 years with a BMI of between 30 and 34 were almost twice as likely to be admitted to ICU compared to patients with a BMI of less than 30. This likelihood increased to 3.6 times in those patients with a BMI of 35 or greater.
In patients over 60 years, the researchers didn’t find a significant link between obesity and severe illness (as indicated by admission to ICU).
Another study, which recorded weight for 178 patients, found obesity was the most common underlying condition for patients aged under 64 years admitted to hospital for COVID-19.
Why the greater risk?
Taken together, the above data suggest there is an association between obesity and more severe COVID-19 illness, particularly in those with a BMI of 35 or greater.
The US Centers for Disease Control and Prevention (CDC) now lists “severe obesity” as a risk factor for serious COVID-19 illness.
We don’t know exactly what role obesity plays in the severity of COVID-19 symptoms. But the mechanisms are likely to be multifaceted, particularly since obesity itself is the result of a complex interaction between genetic, hormonal, behavioural, social and environmental factors.
We know obesity can have a significant impact on lung function. Excess weight around the abdomen can compress the chest, making it more difficult for the diaphragm to move and the lungs to expand and take in air. This can contribute to lower levels of oxygen in the blood, which may exacerbate the symptoms of COVID-19.
We also know obesity results in a chronic state of inflammation which can impair the body’s immune response. This could potentially make it more difficult for the body to fight coronavirus.
The challenges in caring for patients with severe obesity may also affect their outcomes from COVID-19.
For example, it’s more difficult to intubate or perform imaging such as X-rays and CT scans in patients with obesity.
Further, positioning ventilated patients on their stomachs can increase the amount of oxygen entering the lungs. But this is often not possible for patients with severe obesity.
Amanda Salis receives funding for her research from the National Health and Medical Research Council (NHMRC) of Australia. She owns 50% of the shares in Zuman International Pty Ltd, a company that receives income (e.g. royalties) from her books and education about adult weight management.
Andrea Pattinson does not work for, consult, own shares in or receive funding from any company or organisation that would benefit from this article, and has disclosed no relevant affiliations beyond their academic appointment.
This article was originally published on The Conversation, you can read the original article here